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Background: Lung cancer is one of the most frequent malignancies, with high mortality rates. It can metastasize in
almost all organs, but more often invades hilar nodes, liver, adrenal glands, bones and brain. There are various data
on the incidence of lung cancer metastases in the skin. In 1-12% of patients with lung cancer are developed skin
metastases. Metastases in the skin may be the first sign of lung cancer.
Case presentation: Forty-five years old Albanian male, smoker, was admitted to our department with multiple
nodules localized in the skin of the head, neck, back and chest. The nodules measuring 5–15 millimeters in greatest
dimension were round and skin-colored, with telangiectasias, firm and tender. They appeared in an eruptive form
about two weeks before being admitted at our hospital. In addition, the patient exhibited signs of weight loss,
anorexia and fatigue.
Excisional biopsy was performed to one of the lesions. Histopathology confirmed metastatic nature of the lesion
namely, malignant tumor of neuroendocrine phenotype consistent with small-cell carcinoma.
Chest X-ray and computed tomography revealed an expansive process in the 7th segment of the left lung, left hilar
and mediastinal lymphadenopathy and a suspicious initial secondary deposit in the left adrenal gland. The patient
was referred to the department of oncology for further treatment. After the third cycle of chemotherapy, the
magnetic resonance imaging revealed brain metastases. The patient passed away four months after the diagnosis
of lung cancer first presented with skin metastases.
Conclusions: Metastases in skin may be the first sign of lung cancer. Although rare appearing, we should raise
suspicion in cases of atypical lesions in the skin not only of the smokers, but also of the non-smokers. Skin metastases
from small-cell lung carcinoma are a poor prognostic indicator. The appearance of multiple skin metastases with other
internal metastases shorten the survival time.
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Lung cancer is one of the most frequent malignancies
with high mortality rate [1]. It may metastasize in almost
all organs, but more frequent sites are hilar nodes, liver,
adrenal glands, bones and brain [2,3]. There are various
data on the incidence of lung cancer metastases in the
skin. According to some data, in men, lung cancer is
ranked first with skin metastases (24%), compared to
other malignancies [4]. In women, lung cancer is ranked
fourth (4%) with skin metastases, following breast can-
cer, colorectal cancer, melanoma and ovarian cancer [4].
The incidence of skin metastases from lung cancer var-
ies between 1-12% of cases [5]. All histological types of* Correspondence: laurapajaziti@gmail.com
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unless otherwise stated.lung cancer may develop metastases in the skin. Metas-
tases from lung cancer may be the first sign of lung can-
cer and clinically cannot be distinguished from skin
metastases originated from other organs [6]. Most com-
mon sites of skin metastases from lung cancer are the
chest, abdomen, head and neck [6-8]. Clinically, skin
metastases occur as round or oval nodules, mobile or
fixed, firm, skin-colored (sometimes red, dark red or
black). The nodules are usually painless, sometimes may
ulcerate. They may rarely appear in the form of solitary
or grouped papules, plaque-like, zosteriform, erysipelas-
like or as cicatricial alopecia on the scalp [6,9-11]. Com-
pared to other internal malignancies, lung cancer is the
fastest in developing skin metastases after initial diagno-
sis [12]. The occurrence of cutaneous metastases from
lung cancer is a poor prognostic indicator [13]. Coexist-
ence of skin metastases with other extracutaneousThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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mately three months [14]. The survival time can last up to
ten months in cases with skin metastases only [15].
Case presentation
Forty-five years old Albanian male, smoker, was admit-
ted to our department with multiple skin nodules local-
ized in the head, neck, back and chest. The nodules
were firm, tender, skin-colored and measured 5-15 milli-
meters in greatest dimension (Figure 1). They occurred
two weeks before being admitted. In addition, the pa-
tient exhibited signs of weight loss, anorexia and fatigue,
but no symptoms related to respiratory system. Exci-
sional biopsy was performed to one of the lesions. Histo-
pathology confirmed metastatic nature of the lesion
namely, malignant tumor of neuroendocrine phenotype
consistent with small-cell carcinoma (SCC). The pattern
consisted of grouped small cells, oval or fusiform, with
large hyperchromatic nuclei. In immunohistochemistry,
tumor cells were positive for Pan Cytokeratin (CK-
MNF), CD-56 and Synaptophysin. There was no expres-
sion of Cytokeratin 7 or Cytokeratin 20. Leukocyte
Common Antigen (LCA, CD45) was positive in scat-
tered inflammatory cells of the tumor stroma (Figure 2).
Proliferative index as measured by Ki-67 was high
(approximately 99% of tumor cells). The bronchoscopic
biopsy was nondiagnostic.
Subsequently, chest X-ray (CXR) showed obliteration
of the left costophrenic angle and increased inhomogen-
ous density in the left perihilar zone (Figure 3).
Computed tomography (CT) revealed an expansive
process in the left lung, left hilar and mediastinal lymph-
adenopathy (Figure 4) and a suspicious secondary initial
deposit in the left adrenal gland. Bone scan was unre-
markable. Laboratory results were within normal limits,
except values of lactate dehydrogenase (LDH) which wasFigure 1 (a, b) Multiple nodules on the back and a nodule with telangiectslightly elevated namely, 556 U/l (230-460) and C- reactive
protein (CRP) with values of 15.4 mg/l (0 to 5.0). The pa-
tient was referred to the department of oncology where he
underwent chemotherapy with cisplatin 130 mg and eto-
poside 180 mg with poor clinical response. Meanwhile,
skin metastases increased in number and occurred also in
the region of the face.
After the third cycle of chemotherapy, magnetic reson-
ance imaging (MRI) revealed multiple brain metastases
located in the cortex of the temporal lobe, left cerebel-
lum, orbital adipose tissue, bilateral extraocular muscles
and left lacrimal gland region (Figure 5). The patient
passed away four months after the lung cancer diagnosis.
Skin metastases were the first sign.
Discussion
Lung cancer metastases in the skin are rare [3,16]. In lit-
erature there are various data regarding the frequency of
their development. Patients with lung cancer develop
skin metastases in ranges form 1-12% [3,5]. Although it
was thought that lung cancer has the highest incidence
of skin metastasizing in men [4], recent studies have
shown that melanoma leads with skin metastases
(32.3%) in men. In women, lung cancer develops metas-
tases in the skin in 2% of cases [17]. It is reported that
in 25% of cases of lung cancer, skin is the first site of
metastasis [15]. However, in large series of studies, there
are reports that the skin is the 13th common site of lung
cancer metastasizing [18], while hilar nodes, liver, ad-
renal glands, bones and brain are more frequent sites
[2,3]. In a retrospective study with 80 cases [19], the ad-
justed skin metastasis prevalence data of various inner
cancers indicated that kidney-, lung- and colorectal can-
cers have a strong positive preference for skin metastati-
sation. Most skin metastases occur in regions close to
the primary cancer. A number of cancers demonstrate aasias.
Figure 2 Immunohistochemical stain highlighting neuroendocrine nature of the tumor cells. Cytokeratin 20 (not shown) was negative.
Figure 3 Chest X-ray showed obliteration of the left costophrenic
angle and increased inhomogenous density in the left parahilar zone.
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cer to the supradiaphragmatic (mostly chest) and colo-
rectal cancers to the infradiaphragmatic (abdominal)
skin regions [19,20]. It was also found that cancer of the
upper lobes of the lungs have a greater tendency to me-
tastasizing in skin [21,22]. These findings are clinically
relevant and useful especially in patients where skin
metastasis is the first indication of a malignancy [20].
Metastasis of human cancer is an organ-selective process
that is determined by anatomical and biological factors
as well as by specific microenvironmental properties
[20]. The precise mechanisms determining the tropism
of lung cancer for skin remain unsolved. In small-cell
lung cancer, metastatic disease often appears at the time
of or shortly after the initial diagnosis [23]. Several re-
cent studies indicate that there are unique genes and
gene signatures that modulate specific tropisms of a pri-
mary tumor [24]. All histological types of lung cancer
may develop metastases in the skin [15]. In literature,
various data are reported related to the frequency of skin
metastases of different histological types of lung cancer.
Some studies demonstrate that adenocarcinoma (ACC)
is the most common type of lung cancer that develops
skin metastases [4,5,25]. Terashima and Coslett reported
in their studies that large-cell carcinoma (LCC) has the
Figure 4 (a, b) Computed tomography revealed an expansive process in the left lung, left hilar and mediastinal lymphadenopathy.
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SCC rarely develops metastases in the skin [21,26,27].In
our case, the primary cancer was a micro-cellular carcin-
oma located on the lower left lobe. Skin metastases were
the first sign. Although the literature describes casesFigure 5 (a, b) Magnetic resonance imaging of metastases located in the
hemisphere (b).where metastatic nodules are painless, our patient had
painful nodules which made uncomfortable lying pos-
ition. Cutaneous metastases in the facial region occur in
less than 0.5% of patients with metastatic cancer [28]. In
a report [28], an unusual case of small-cell lung cancercortex of the temporal lobe, scalp (a) and in the left cerebellar
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is described. In our case, facial metastases occurred dur-
ing chemotherapy. Metastases in skin occur when the
disease has progressed and are indicator of poor progno-
sis and short survival [2,6,13]. There are reports that the
survival time after the appearance of skin metastases is
about 5-6 months [3]. Patients that present with skin
metastases earlier during the disease course, have poorer
prognosis compared to those with later developed me-
tastases [29]. The prognosis is poorer in cases where ex-
cept cutaneous metastases there are extracutaneous
metastases also [14]. Non-resectable primary tumor or
small-cell carcinoma is another poor prognostic indica-
tor [15]. Our patient had three poor prognostic indica-
tors: primary micro-cellular inoperable tumor, multiple
cutaneous metastases and other distant metastases.
Conclusion
Metastases in skin may be the first sign of lung cancer.
Due to the non- specific appearance, they can be misdiag-
nosed as benign lesions. In our case, supradiaphragmatic
location of non-specific skin lesions, weight loss, and posi-
tive smoking history indicated suspicion for lung cancer.
Even though skin metastases from lung cancer are rare,
we should suspect on it in cases of atypical lesions in the
skin in smokers as well as in non smokers. Skin metastases
from lung cancer are a poor prognostic indicator. The
prognosis is poorer when small-cell lung carcinoma is the
primary. The appearance of multiple skin metastases with
other internal metastases shorten the survival time.
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